Literature DB >> 20805751

Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism.

Morten Søndergaard Jensen1, Cristina Rebordosa, Ane Marie Thulstrup, Gunnar Toft, Henrik Toft Sørensen, Jens Peter Bonde, Tine Brink Henriksen, Jørn Olsen.   

Abstract

BACKGROUND: Cyclooxygenase (COX) inhibitors-acetaminophen, ibuprofen and acetylsalicylic acid-have endocrine-disruptive properties in the rainbow trout. In humans, aspirin blocks the androgen response to human chorionic gonadotropin (hCG), and, because hCG-stimulated androgen production in utero is crucial for normal testicular descent, exposure to COX inhibitors at vulnerable times during gestation may impair testicular descent. We examined whether prenatal exposure to acetaminophen, ibuprofen, and acetylsalicylic acid was associated with increased occurrence of cryptorchidism.
METHODS: Our study used data on 47,400 live-born singleton sons of mothers enrolled in the Danish National Birth Cohort during 1996-2002. Cryptorchidism was identified in 980 boys during childhood, of whom 565 underwent orchiopexy. The use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy was assessed in 3 computer-assisted telephone interviews and 1 self-administered questionnaire. We estimated adjusted hazard ratios (HRs) of cryptorchidism by Cox regression analysis.
RESULTS: Exposure to acetaminophen during both the first and second trimesters was associated with increased occurrence of cryptorchidism (HR = 1.33 [95% confidence interval = 1.00-1.77]). Exposure for more than 4 weeks within the postulated time-window of programming testicular descent (gestational weeks 8-14) was associated with a HR of 1.38 (1.05-1.83) for cryptorchidism. Exposure to ibuprofen and acetylsalicylic acid was not associated with cryptorchidism.
CONCLUSION: Maternal intake of acetaminophen for more than 4 weeks during pregnancy, especially during the first and second trimesters, may moderately increase the occurrence of cryptorchidism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20805751     DOI: 10.1097/EDE.0b013e3181f20bed

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  54 in total

1.  Paracetamol-induced endocrine disruption in human fetal testes.

Authors:  Bernard Jégou
Journal:  Nat Rev Endocrinol       Date:  2015-06-30       Impact factor: 43.330

2.  A risk assessment of a common drug using xenograft model.

Authors:  Masami Kodama; Junko Kurokawa
Journal:  Ann Transl Med       Date:  2017-02

3.  Prolonged exposure to acetaminophen during pregnancy reduces testosterone production by the human fetal testis.

Authors:  Mehmet Gokhan Culha; Ege Can Serefoglu
Journal:  Ann Transl Med       Date:  2017-05

4.  Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals.

Authors:  Shakila Sabir; Muhammad Furqan Akhtar; Ammara Saleem
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-22       Impact factor: 4.223

5.  Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit/Hyperactivity Disorder in Nurses' Health Study II.

Authors:  Zeyan Liew; Marianthi-Anna Kioumourtzoglou; Andrea L Roberts; Éilis J O'Reilly; Alberto Ascherio; Marc G Weisskopf
Journal:  Am J Epidemiol       Date:  2019-04-01       Impact factor: 4.897

6.  Urinary paracetamol and time-to-pregnancy.

Authors:  Melissa M Smarr; Katherine L Grantz; Rajeshwari Sundaram; José M Maisog; Masato Honda; Kurunthachalam Kannan; Germaine M Buck Louis
Journal:  Hum Reprod       Date:  2016-07-13       Impact factor: 6.918

7.  Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child.

Authors:  Tanja Gram Petersen; Zeyan Liew; Anne-Marie Nybo Andersen; Guro L Andersen; Per Kragh Andersen; Torben Martinussen; Jørn Olsen; Cristina Rebordosa; Mette Christophersen Tollånes; Peter Uldall; Allen J Wilcox; Katrine Strandberg-Larsen
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

8.  [Systemic drug treatment during pregnancy].

Authors:  Maximilian Riedel; Bettina Kuschel
Journal:  Hautarzt       Date:  2020-04       Impact factor: 0.751

Review 9.  Analgesic use in pregnancy and male reproductive development.

Authors:  Pablo Hurtado-Gonzalez; Rod T Mitchell
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-06       Impact factor: 3.243

Review 10.  Analgesia use during pregnancy and risk of cryptorchidism: a systematic review and meta-analysis.

Authors:  Jason Gurney; Lorenzo Richiardi; Katherine A McGlynn; Virginia Signal; Diana Sarfati
Journal:  Hum Reprod       Date:  2017-05-01       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.